8.20Open8.20Pre Close0 Volume4 Open Interest72.00Strike Price0.00Turnover1530.78%IV3.90%PremiumDec 13, 2024Expiry Date5.19Intrinsic Value100Multiplier-1DDays to Expiry3.01Extrinsic Value100Contract SizeAmericanOptions Type0.9931Delta0.0088Gamma14.99Leverage Ratio-14.7043Theta0.0000Rho14.88Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet